Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 220

recruiting
3 973
countries
28
conditions
2 104

10 286 trials match your criteria

Study Comparing Dosimetry-Based PRRT and Standard Dose PRRT with Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) edotreotide

Study of Selinexor, Bortezomib, and Lenalidomide with Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Not Eligible for Transplant

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib

Study on the Effects of Siponimod on Imaging and Immune Markers in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Siponimod

Study of Intra-Arterial Infusion of Lutetium (177Lu) Oxodotreotide for Adults with Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine Besilate
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

Study on Pancreatic Enzyme Replacement Therapy for Adults with Pancreatic Exocrine Insufficiency After Pancreatic Surgery

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Pancreas Powder

Sedative therapy+1

Recruiting

Study on Intranasal Dexmedetomidine for Sedation and Pain Relief in Children Undergoing Minor Procedures in the Emergency Room

Registered drug
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Dexmedetomidine

Breast cancer+4

Recruiting

Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib

Colonoscopy

Recruiting

Study Comparing Bowel Cleansing Agents Plenvu and Picoprep for Patients Undergoing Colonoscopy to Exclude Colorectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid

Study of Elenestinib for Patients with Indolent Systemic Mastocytosis

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate

Study of Rituximab for Patients with Psychosis or Obsessive-Compulsive Disorder Linked to Immune System Involvement

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Rituximab

Diabetic foot

Recruiting

Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.